D-dimer level and lymphocyte to white blood cell count ratio could be a predictor of mechanical ventilation therapy in patients with coronavirus disease 2019

被引:1
作者
Fujino M. [1 ]
Hamanaka K. [1 ]
Hitosugi M. [2 ]
机构
[1] Department of Critical Care and Emergency Medicine, Otsu City Hospital, 2-9-9, Motomiya, Otsu
[2] Department of Legal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu
关键词
cytokine storm; D-dimer; lymphocyte to white blood cell ratio; novel coronavirus disease 2019; respiratory failure;
D O I
10.17106/jbr.36.45
中图分类号
学科分类号
摘要
Some symptomatic patients with coronavirus disease 2019 (COVID-19) develop acute respiratory failure with mechanical ventilation support. Therefore, identifying patients who tend to experience respiratory deterioration is of great importance. We investigated blood markers upon hospital admission that could predict respiratory illness in patients with COVID-19. This retrospective observational study included 148 patients with COVID-19 admitted to our hospital. All blood marker levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), D-dimer, white blood cells (WBCs), and lymphocytes were measured on admission in 148 patients. Patients were divided into the severe group (SVG), requiring mechanical ventilation therapy, and the non-severe group (nSVG). The levels of CRP, LDH, D-dimer and WBC count were significantly higher, and the lymphocyte count and lymphocyte-to-WBC count ratio (LWR) were significantly lower in the SVG than in the nSVG. The area under the receiver operating characteristic curve for CRP, LDH, D-dimer and LWR showed high values of 0.69, 0.70, 0.70, and 0.74, respectively. The age-adjusted odds ratios of D-dimer and LWR were high (5.5 [1.9–15.9] and 5.6 [2.2–14.3], respectively). D-dimer level and LWR upon admission were highly predictive of mechanical ventilation support in patients with COVID-19. © Japanese Society of Biorheology 2022.
引用
收藏
页码:45 / 50
页数:5
相关论文
共 17 条
[11]  
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T., Biomarkers associated with COVID-19 disease progression, Crit Rev Clin Lab Sci, 57, pp. 389-399, (2020)
[12]  
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Et al., Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China, Clin Infect Dis, 71, pp. 762-768, (2020)
[13]  
Deng Y, Liu W, Liu K, Fang Y-Y, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Et al., Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study, Chin Med J (Engl), 133, pp. 1261-1267, (2020)
[14]  
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Et al., Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China Supplemental content, JAMA Intern Med, 180, pp. 934-943, (2020)
[15]  
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, pp. 1054-1062, (2020)
[16]  
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Et al., Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogene-sis in Covid-19, N Engl J Med, 383, pp. 120-128, (2020)
[17]  
McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C., Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia, Lancet Rheumatol, 2, pp. e437-e445, (2020)